Pfizer-BioNTech and Moderna to Earn $14.7B from COVID-19 Vaccines Sales by 2023
The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the lion’s